Available Technologies

Browse Penn-owned technologies available for licensing.

HOME SEARCH RSS FEED

Search Results - matthias hammers

1 Results Sort By:
Recombinant antibody fragments for targeted treatment of autoimmune skin disease
Recombinant antibodies for diagnosis, treatment, and targeted drug delivery in skin disease. Technology Overview: Bullous pemphigoid (BP) is an autoantibody-mediated blistering skin disease in which the epidermal cells lose adhesion to the basement membrane. Patients feature circulating and tissue-bound autoantibodies that target two basement...
Published: 11/15/2019   |   Inventor(s): Matthias Hammers, Donald Siegel, John Stanley
Keywords(s):  
Category(s): Diagnostics, Therapeutics & Vaccines